Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein–Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor Growth

Infectious diseases are linked to 15%–20% of cancers worldwide. Among them, Epstein–Barr virus (EBV) is an oncogenic herpesvirus that chronically infects over 90% of the adult population, with over 200,000 cases of cancer and 150,000 cancer-related deaths attributed to it yearly. Acute EBV infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Wojtak, Krzysztof, Perales-Puchalt, Alfredo, Weiner, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631996/
https://www.ncbi.nlm.nih.gov/pubmed/31137606
http://dx.doi.org/10.3390/vaccines7020044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631996/
https://www.ncbi.nlm.nih.gov/pubmed/31137606
http://dx.doi.org/10.3390/vaccines7020044

Ejemplares similares